|
 |
MecamylamineThis page contains recent news articles, when available, and an overview of Mecamylamine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Mecamylamine (when available) Mecamylamine is a potent, oral antihypertensive agent and ganglion blocker, and is a secondary amine. Mecamylamine is indicated for the management of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension. Mecamylamine reduces blood pressure in both normotensive and hypertensive individuals. A small oral dosage often produces a smooth and predictable reduction of blood pressure. Although this antihypertensive effect is predominantly orthostatic, the supine blood pressure is also significantly reduced. Mecamylamine crosses the blood-brain and placental barriers. For the treatment of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension Mechanism Of Action: Mecamylamine is a ganglionic blocker which prevents stimulation of postsynaptic receptors by acetylcholine released from presynaptic nerve endings. The hypotensive effect of Mecamylamine is attributed to reduction in sympathetic tone, vasodilation, and reduced cardiac output, and is primarily postural. News Articles on Mecamylamine … To Develop Enantiomer Of Mecamylamine As Augmentation Therapy For … - Oct 25, 2007 Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics (TM), announced plans ... Medical News Today - Medical News Today (press release) Mecamylamine (Systemic).(Drug overview) - May 1, 2006 Mecamylamine (mek-a-MILL-a-meen) belongs to the general class of medicines called antihypertensives. It is used to treat high blood pressure (hypertension). ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Mecamylamine (Systemic). - Feb 1, 2006 Mecamylamine (mek-a-MILL-a-meen) belongs to the general class of medicines called antihypertensives. It is used to treat high blood pressure (hypertension). ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Figure 4 : Acetylcholine contributes through muscarinic receptors to ... - Aug 28, 2008 ROC values were not significantly affected by mecamylamine application. Error bars show the sem. If the slide opens in your browser, select " File > Save As ... Nature.com … to Develop Enantiomer of Mecamylamine as Augmentation Therapy for ... - Oct 31, 2007 WINSTON-SALEM, NC -- Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics ... carolinanewswire.com Mecamylamine Shows Promise in Treating Major Depression: Presented … - Oct 18, 2007 By Joanna Lyford. VIENNA, AUSTRIA -- October 18, 2007 -- Mecamylamine, a drug approved for treating hypertension, may be an effective augmentation therapy ... DG News Targacept reports progress in depression treatment The Business... - Nov 9, 2006 The trial is of mecamylamine hydrochloride, which the company believes may be able to enhance a commonly prescribed depression treatment that is sold under ... Bizjournals.com … Showing Positive Effects of Mecamylamine as Augmentation Treatment - Jul 24, 2007 The data suggest that an add-on treatment of mecamylamine hydrochloride, ... "NNR antagonists like mecamylamine may be an important new therapy for treating ... Genetic Engineering News - Genetic Engineering News (press release) Targacept Initiates Phase 2b Clinical Trial of TC-5214 as Augmentation... - Jul 21, 2008 TC-5214 is the S(+) enantiomer of mecamylamine hydrochloride. TC-5214 has exhibited an overall therapeutic profile superior to mecamylamine in preclinical ... Lifescience-online AGI Therapeutics plc announces Research Update - Feb 5, 2008 AGI-004, a low-dose controlled release form of mecamylamine, is a potent, ... The dose of mecamylamine will be escalated over the two cycles. ... marketwire.com Targacept to Develop Enantiomer of Mecamylamine for Depression - Oct 24, 2007 Targacept plans to advance TC-5214, one of two enantiomers of mecamylamine hydrochloride, into clinical development as an augmentation therapy for patients ... FDA news - FDA news (subscription) Athenagen Raises $5.7M For New Angiogenesis Pathway. - Sep 20, 2005 That product and the mecamylamine drug for AMD both are expected to begin trials next year. Athenagen is considering pursuing development and ... Pay-Per-View - BIOWORLD Today - Factiva, from Dow Jones ALSO NOTED: MedImmune sells CytoGam; Targacept reports mixed data … - Nov 8, 2006 Targacept is reporting mixed results from its late stage trial of the depression therapy mecamylamine taken with citalopram hydrobromide (Celexa). ... FierceBiotech AGI's losses soar as it invests heavily in R&D - Apr 4, 2008 AGI is also developing other drugs such as mecamylamine, planned to treat chemotherapy-induced diarrhoea. Mr Devane said that Phase II clinical trials for ... Irish Independent Targacept announces positive mecamylamine HCl data. - Jul 30, 2007 Targacept announces positive mecamylamine HCl data. US clinical-stage biopharmaceutical company Targacept says that data suggest that mecamylamine HCl, ... $9.94 - Pharma Marketletter - Alacra Store Targacept Initiates Phase I Clinical Trial of TC-2216. - Jan 8, 2007 Mecamylamine hydrochloride binds non-selectively to various NNR subtypes, but there is a body of scientific evidence that suggests that its anti-depressant ... Free with registration - PR Newswire - AccessMyLibrary.com Acetylcholine contributes through muscarinic receptors to attentional... - Jan 1, 2008 Significant effects of attention and of mecamylamine application, ... There was no interaction between mecamylamine applied/not-applied and bar length (F ... Nature.com CoMentis initiates phase 2 trial of topical AMD drug - Apr 18, 2007 CoMentis Inc. has initiated a phase 2 clinical study evaluating a topical ophthalmic formulation of mecamylamine for treating neovascular age-related ... OSN SuperSite Antihypertensive's antidepressant effects explored.(Mental Health) - Jan 1, 2008 VIENNA -- Mecamylamine, an old, rarely prescribed, truly obscure antihypertensive agent, may be favorably reincarnated as an antidepressant with a ... Free with registration - Family Practice News - AccessMyLibrary.com Targacept to advance drug into clinicals. - Oct 29, 2007 TC-5214 is the S+ enantiomer of mecamylamine. ... In light of the Phase II results with mecamylamine described above, these findings suggest the compelling ... $4.95 - Pharma Marketletter - ECNext Insight into Alcohol-Nicotine Interaction Might Lead to New Quitting ... - Mar 15, 2005 While alcohol boosted the rewarding experience of nicotine, mecamylamine had ... Mecamylamine might offer a novel treatment to help smokers who also drink ... emaxhealth.com Targacept Initiates Clinical Development of TC-5214 as Augmentation … - Mar 17, 2008 TC-5214 is the S(+) enantiomer of the racemate mecamylamine hydrochloride, ... Targacept previously conducted a Phase 2 trial of racemic mecamylamine in 184 ... Genetic Engineering News - Genetic Engineering News (press release) AGI Therapeutics plc - Product Update. - Feb 15, 2007 Mecamylamine and Arbaclofen a We recently reported results for controlled ... AGI believes that controlled release mecamylamine has the potential to be an ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com Article: Antihypertensive's antidepressant effects explored.(Mental... - Jan 1, 2008 VIENNA -- Mecamylamine, an old, rarely prescribed, truly obscure antihypertensive agent, may be favorably rei... Pay-Per-View - Family Practice News - HighBeam Research ABC News' Dr. Tim Answers Questions About Smoking - Nov 10, 2005 There are three other medications that can be used: nortriptyline, clonidine, and mecamylamine. Like Zyban, Nortriptyline is also an antidepressant; ... ABC News Targacept Scientists Make Multiple Presentations at Society for … - Nov 20, 2008 In addition, a paper titled "TC-5214 (S-(+)-Mecamylamine): A Neuronal Nicotinic ... TC-5214 is the S(+) enantiomer of mecamylamine hydrochloride and has ... International Business Times QuitPak enters pilot study - Feb 13, 2007 The new therapy, which combines bupropion and mecamylamine, ... Until 1997 Merck marketed mecamylamine as a hypertension treatment under the name Inversine, ... In-PharmaTechnologist.com Biological processes underlying co-use of alcohol and nicotine:... - Sep 22, 2006 Another approach to analyzing alcohol-nicotine interactions involves a substance called mecamylamine, a nicotinic receptor antagonist. ... $4.95 - Alcohol Research & Health - ECNext Nicotine Helps Schizophrenia Patients with Attention and Memory … - Jun 23, 2005 Mecamylamine blocked the ability of smoking to improve cognitive deficits in schizophrenia, but not in persons without mental illness. ... Medical News Today - Medical News Today (press release) Nicotine Helps Schizophrenics With Attention And Memory - Jul 11, 2005 Mecamylamine blocked the ability of smoking to improve cognitive deficits in schizophrenia, but not in persons without mental illness. ... sciencedaily.com Athenagen Initiates Clinical Development Of Its Anti-Angiogenic Eye... - Aug 22, 2006 ATG003 is a proprietary topical formulation of mecamylamine that has shown efficacy in animal models and is a possible alternative to current therapies for ... Medical News Today - Medical News Today (press release) Q2 2006 Targacept, Inc. Earnings Conference Call - Final. - Aug 9, 2006 And now, let's move onto mecamylamine hydrochloride. We anticipate that the date from our Phase II trial of mecamylamine as an add therapy for depression ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Press Release: Nicotine helps schizophrenics with attention and... - Jun 23, 2005 Mecamylamine blocked the ability of smoking to improve cognitive deficits in schizophrenia, but not in persons without mental illness. ... Pay-Per-View - M2 Presswire - HighBeam Research Wearing Nicotine Patch Before Stopping Smoking Doubles Quit Rate - Feb 8, 2006 In addition, Rose plans to continue studies using mecamylamine and the nicotine patch prior to the target quit date. Previous studies suggest that the ... DentalPlans.com Stock Market Update, IPO profiles, Earnings Call Transcripts,... - Jan 17, 2006 TC-5231 is a low-dose reformulation of mecamylamine hydrochloride, ... The Company has reformulated mecamylamine hydrochloride as TC-5231 in a liquid gel ... 123Jump.com Targacept's TRIDMAC improves on Celexa.(Brief article) - Nov 20, 2006 The 184-patient trial evaluated the effects of mecamylamine with Forest Laboratories' Celexa (citalopram), a treatment combination called TRIDMAC, ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Topical therapy for CNV on the horizon - Nov 9, 2007 ATG2 (mecamylamine) (CoMentis) is a powerful nonselective nAChR antagonist that ... Topical mecamylamine was seen to penetrate the retina-choroid in mice, ... Ophthalmology Times Press Release: Targacept Announces Positive Results of Phase II... - Nov 9, 2006 The trial (n=184) evaluated the effects of mecamylamine taken with citalopram hydrobromide, a treatment combination known as TRIDMAC, in patients who did ... Pay-Per-View - PR Newswire - HighBeam Research IntelGenx Technologies Corp. and Cary Pharmaceuticals Inc. Today … - May 3, 2007 The plasma profiles of Bupropion and Mecamylamine after administration to 7 of a total of 10 subjects demonstrate that the once-daily formulation meets the ... ccnmatthews.com IntelGenx Technologies Corp. and Cary Pharmaceuticals Inc. Announce … - Feb 7, 2007 QuitPak ® is Cary's proprietary combination product containing Bupropion and Mecamylamine and is intended as an alternative therapy in smoking cessation. ... ccnmatthews.com Ameliorating the developmental neurotoxicity of chlorpyrifos: a … - Sep 1, 2007 ...the effects of CPF: the combination of atropine plus mecamylamine (antagonists toward muscarinic and nicotinic acetylcholine receptors, respectively); ... Free with registration - Environmental Health Perspectives - AccessMyLibrary.com Drug Developed in 50s Will Be Tested in Autism Cases - Oct 31, 2007 It's a drug called mecamylamine, and it was the first pill used to treat ... Mecamylamine has been effective in helping children control the symptoms of ... DentalPlans.com Autonomic Hyperreflexia - Symptoms, Diagnosis, Treatment of Autonomic... - May 29, 2008 ...include: Nifedipine (Procardia), Nitroglycerine, Phenoxybenzamine hydrochloride (Dibenzyline), Mecamylamine (Inversine), and Diazoxide (Hyperstat). ... New York Times Antismoking Pill May Ease Depression ... Or Cause Suicidal Thoughts - Mar 13, 2008 George has tested the antidepressant-assisting effects of the blood pressure drug Inversine (mecamylamine), which blocks nicotinic receptors, ... Wired News Targacept Reports Fourth Quarter and 2006 Financial Results. - Feb 22, 2007 Announced positive top line results of the Phase II clinical trial of mecamylamine hydrochloride as an augmentation therapy to citalopram hydrobromide, ... $4.95 - PR Newswire - ECNext Targacept Reports Third Quarter 2007 Financial Results.(Financial... - Nov 8, 2007 In addition, we believe that the results of our Phase II clinical trial of mecamylamine hydrochloride as an augmentation therapy for major depression and ... $4.95 - Business Wire - ECNext AGI reports good initial results from two Ph II trials. - Feb 5, 2007 Data from the mecamylamine study suggests that the agent has a beneficial effect on certain diarrhea-related symptoms, particularly in terms of stool ... $9.94 - Pharma Marketletter - Alacra Store Targacept and AstraZeneca Announce Global License and Research … - Dec 28, 2005 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in clinical development for cognitive impairment, ... Free with registration - PR Newswire - AccessMyLibrary.com Promising treatments target depression, aim at body's response to... - Dec 14, 2006 Targacept Inc. just finished a midstage study showing that mecamylamine, an old blood-pressure drug it got from Merck, acts as an antidepressant by working ... Pittsburgh Post-Gazette - Pittsburgh Post Gazette Targacept compounds show long-lasting improvement in cognition - Jul 2, 2005 Targacept has a marketed product, Inversineо (mecamylamine hydrochloride), product candidates in clinical development for cognitive impairment, ... Medical News Today - Medical News Today (press release) Ispronicline Joins Effort to Find Alzheimer's Cure - Jul 6, 2005 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in clinical development for cognitive impairment, ... SeniorJournal.com Targacept compounds show long-lasting improvement in cognition - Jul 5, 2005 Targacept has a marketed product, Inversine® ( mecamylamine hydrochloride ), product candidates in clinical development for cognitive impairment, ... i-newswire.com Effects of Nicotine Nasal Spray on Cognitive Function in Schizophrenia - Sep 14, 2005 ...who had been abstinent from smoking overnight, and interference with this effect by a cholinergic antagonist mecamylamine. However, in the George study, ... Nature.com Nicotine abstinence genotyping: assessing the impact on smoking … - Sep 9, 2008 ...from smoking after treatment with nicotine replacement and mecamylamine vs research volunteers who were not abstinent at this 6-week time point. 10 ... Nature.com Targacept Announces Positive Phase II Results for TC-1734 (AZD3480) … - May 17, 2006 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in development for Alzheimer's disease and cognitive ... Free with registration - PR Newswire - AccessMyLibrary.com What about Provasin for nightmares from PTSD? - Jun 10, 2008 Provasin is a name brand for Mecamylamine which used to be prescribed for high blood pressure. It was discontinued as a high blood pressure medication ... HealthCentral.com Targacept to Present at Pacific Growth Equities 2005 Life Sciences … - Jun 2, 2005 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in clinical development for cognitive impairment, ... $4.95 - PR Newswire - ECNext CASM, GRRF, HIMX, TRGT, TZOO, WIT Have Been Removed From … - May 11, 2006 ...the treatment for acute post-operative pain; and TC-5214, a preclinical product candidate, which is a molecular component of mecamylamine hydrochloride. ... Free with registration - M2 Presswire - AccessMyLibrary.com PAR-TAY; FREEWEBS; CARY PHARMA - Tech Bisnow - Washington - Aug 1, 2008 QuitPak combines two drugs, mecamylamine (blocks nicotine receptors) and bupropion (slows nicotine cravings), both used to cure smoking, ... Bisnow Drug treatment for alcoholism today. - Jul 1, 2005 In early research, a skin patch containing mecamylamine has shown some promise; this drug is now used to help smokers quit. Baclofen, another drug that ... $4.95 - Harvard Mental Health Letter - ECNext Imprivata OneSign FastPass Provides Quick and Secure One-Touch Log- … - Sep 9, 2008 The initiation in February of a Phase II clinical study of AGI- 004, a transdermal mecamylamine patch being developed for the treatment of ... marketwire.com Effect of nicotine on IL-18-initiated immune response in human … - Jul 18, 2006 A nonselective and a selective 7-nAChR antagonist, mecamylamine, and -bungarotoxin abolished the effects of nicotine, suggesting that this depends on ... Journal of Leukocyte Biology (subscripti... JDRF Partners with CoMentis for Diabetic Macular Edema Clinical Trial - Sep 20, 2007 ATG3, a proprietary formulation, of mecamylamine that is also in development for the treatment of age-related macular degeneration (AMD), is an antagonist ... Genetic Engineering News - Genetic Engineering News (press release) Targacept to expand facilities at Piedmont Triad Research Park - Jan 31, 2007 In November 2006, Targacept reported positive top line results from a Phase II clinical trial of TRIDMAC(TM), which evaluated mecamylamine hydrochloride as ... carolinanewswire.com CoMentis Initiates Phase II Clinical Trial for AMD Eye Drop Therapy - Apr 10, 2007 A proprietary ophthalmic formulation of mecamylamine, ATG3 is an antagonist of the nicotinic acetylcholine (nACh) receptor pathway that mediates ... Genetic Engineering News - Genetic Engineering News (press release) Multiple Studies on Autism Under Way at OSU Medical Center - Sep 24, 2007 The agent to be tested in children with autism, mecamylamine, has been shown to be safe in other childhood-onset disorders, including Tourette's syndrome ... DentalPlans.com Study may spur treatments to protect brain from chlorpyrifos.(RESEARCH... - Sep 10, 2007 The cholinergic receptor antagonists atropine and mecamylamine offered little or no protective effect of undifferentiated PC12 cells exposed to chlorpyrifos ... Free with registration - Pesticide & Toxic Chemical News - AccessMyLibrary.com Cognitive dysfunctions in schizophrenia: potential benefits of … - Nov 1, 2006 ...scopolamine and atropine) and nicotinic-cholinergic antagonists (e.g., mecamylamine) have brought about cognitive impairments. ... Free with registration - Journal of Psychiatry and Neuroscience - AccessMyLibrary.com Link Between Smoking and Mental Illness May Lead to Treatments - Feb 1, 2006 ...but such improvements were lacking when these individuals were given mecamylamine hydrochloride, a drug that blocks nicotine's effects. ... Journal of American Medical Association - Journal of American Medical Association... AGI's core product enters phase III trials. - Sep 21, 2007 AGI also plans to initiate phase II clinical studies for its mecamylamine CR and arbaclofen products - for gastroparesis, ulcerative colitis and ... Free with registration - Investors Chronicle - magazine and web... - AccessMyLibrary.com Athenagen's Eye Drop Therapy for AMD Is Safe and Well Tolerated in … - Jan 31, 2007 ATG3, a proprietary ophthalmic formulation of mecamylamine, is an antagonist of the nicotinic acetylcholine (nACh) receptor pathway that mediates ... Genetic Engineering News - Genetic Engineering News (press release) Targacept to Report Second Quarter 2006 Financial Results on August... - Aug 9, 2006 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in development for Alzheimer's disease and cognitive ... prnewswire.com TARGACEPT REPORTS NET LOSS OF 5.5 MIL FOR FIRST QTR 2006. - Jul 1, 2006 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in development for Alzheimer's disease and cognitive ... Entrepreneur A practical clinical approach to the treatment of nicotine dependence... - Sep 1, 2005 There are several promising agents (eg, selegiline, mecamylamine) that have shown initial efficacy and are being examined in larger clinical trials for ... Pay-Per-View - Journal of the American Academy of... - Factiva, from Dow Jones Targacept Presents Promising Results at the 7th International... - Mar 29, 2005 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in clinical development for cognitive impairment, ... $4.95 - PR Newswire - ECNext NFLX, TRGT, TWP, UTK, VNDA, AASP Have Also Been Added To Naked … - Apr 25, 2006 ...the treatment for acute post-operative pain; and TC-5214, a preclinical product candidate, which is a molecular component of mecamylamine hydrochloride. ... $4.95 - M2 Presswire - ECNext Targacept Reports First Quarter 2006 Financial Results. - May 25, 2006 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in development for Alzheimer's disease and cognitive ... $4.95 - PR Newswire - ECNext Targacept Reports Third Quarter 2006 Financial Results. - Nov 9, 2006 Internal Product Development Pipeline * Announced positive top line results of the Phase II clinical trial of mecamylamine hydrochloride as an augmentation ... $4.95 - PR Newswire - ECNext Competitors by Product Report - Sep 30, 2006 Targacept , Inc. (TRGT) Products:. Mecamylamine Hydrochloride; TC-1734 (Ispronicline). Taro Pharmaceutical Industries Ltd. (TARO) Products: ... $75.00 - Revere Reports - Revere AGI Therapeutics plc - Company Snapshot - AlacraStore.com - Nov 12, 2008 ...methodology used to identify existing therapeutic drugs. Product candidates are Rezular, Mecamylamine CR, Omeprazole, Arbaclofen and 4-ASA-Na. ... Pay-Per-View - co - Alacra Store Medical College of Georgia; Plasma volume and mesenteric vascular … - Apr 6, 2005 ..."Ganglionic blockade (mecamylamine, 4 mg/kg) in isoflurane-anesthetized rats produced larger decreases in arterial pressure in OZR compared with LZR (52±2 ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Press Release: CASM, GRRF, HIMX, TRGT, TZOO, WIT Have Been … - May 11, 2006 ...the treatment for acute post-operative pain; and TC-5214, a preclinical product candidate, which is a molecular component of mecamylamine hydrochloride. ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Targacept Reports First Quarter 2007 Financial... - May 9, 2007 Conducted additional preclinical testing and pharmaceutical development of TC-5214, an enantiomer of mecamylamine hydrochloride that the company expects ... Pay-Per-View - PR Newswire - HighBeam Research Museum exhibit shows shift in thinking about tobacco.(News) | Article... - Sep 15, 2006 ..."Mecamylamine ... arousal and vasoconstriction, Dr. Sanberg noted. Dr. Levin pointed out that many pharmaceutical companies and even the tobacco industry ... Pay-Per-View - Family Practice News - HighBeam Research AGI begins dosing in Ph II CID trial. - Feb 11, 2008 Ireland-based drugmaker AGI Therapeutics says that dosing has begun in a Phase II trial of AGI-004 (mecamylamine), its candidate treatment for ... $9.94 - Pharma Marketletter - Alacra Store New treatment options can help smokers quit. | Article from Internal ... - Jul 1, 2008 Golden and Dr. Robert H. Hopkins on the treatment of tobacco dependence did not address mecamylamine ("Smoking Cessation June ... therapies offers the most ... Pay-Per-View - Internal Medicine News - HighBeam Research Treating patients' physical symptoms may improve depression severity.(... - Sep 1, 2005 From a mean HAMD of 20.5 at the start of the double-blind phase, the mecamylamine ... Clinical Psychiatry News. Article: Duloxetine lifts arthritis pain, ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research Press Release: Targacept to Expand Facilities at Piedmont Triad … - Jan 31, 2007 In November 2006, Targacept reported positive top line results from a Phase II clinical trial of TRIDMAC(TM), which evaluated mecamylamine hydrochloride as ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Targacept to Present at the Deutsche Bank 30th Annual ... - Apr 28, 2005 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in clinical development for cognitive impairment, ... Pay-Per-View - PR Newswire - HighBeam Research R&D costs double AGI's 1st-half loss. - Sep 24, 2007 ...three additional pipeline products, including from its arbaclofen and mecamylamine programs, and will initiate Phase II trials in the next few months. ... $9.94 - Pharma Marketletter - Alacra Store Acetylcholine release and choline uptake by cuttlefish (Sepia... - Feb 1, 2008 Furthermore, recent work on cuttlefish optic lobe slices (11) has shown that mecamylamine hydrochloride, a nicotinic receptor antagonist, blocks excitatory ... Pay-Per-View - Biological Bulletin - HighBeam Research AGI's core product enters phase III trials. | Article from Investors... - Sep 21, 2007 AGI also plans to initiate phase II clinical studies for its mecamylamine CR and arbaclofen products - for gastroparesis, ulcerative colitis and ... Pay-Per-View - Investors Chronicle - magazine and web... - HighBeam Research Article: Nicotine patch helps smokers before they quit - University... - Feb 9, 2006 Other research in the program ... mecamylamine in conjunction with the nicotine patch, which has been especially effective ... Nicotine is a very tenacious ... Pay-Per-View - University Wire - HighBeam Research Hypertension; Plasma volume and mesenteric vascular reactivity... - Apr 4, 2005 ..."Ganglionic blockade (mecamylamine, 4 mg/kg) in isoflurane-anesthetized rats produced larger decreases in arterial pressure in OZR compared with LZR (52±2 ... Pay-Per-View - Obesity & Diabetes Week - Factiva, from Dow Jones Targacept to Present at the Deutsche Bank 30th Annual Health Care … - Apr 28, 2005 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in clinical development for cognitive impairment, ... $4.95 - PR Newswire - ECNext Press Release: NFLX, TRGT, TWP, UTK, VNDA, AASP Have Also Been … - Apr 25, 2006 ...the treatment for acute post-operative pain; and TC-5214, a preclinical product candidate, which is a molecular component of mecamylamine hydrochloride. ... Pay-Per-View - M2 Presswire - HighBeam Research DBS improves tic severity in Tourette syndrome patients.( … - Sep 1, 2008 Mecamylamine is a broad-spectrum nicotinic ... anecdotal reports of decreased irritability in patients with Tourette syndrome or autism, so we decided to ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research AGI's loss deepens on flat revenue. - Sep 22, 2008 In February, the firm initiated a Phase II study of AGI-004, a transdermal mecamylamine patch for the treatment of chemotherapy-induced diarrhea. ... $9.94 - Pharma Marketletter - Alacra Store Press Release: Athenagen Initiates Clinical Development of Its Anti- … - Aug 21, 2006 ATG003 is a proprietary topical formulation of mecamylamine that has shown efficacy in animal models and is a possible alternative to current therapies for ... Pay-Per-View - PR Newswire - HighBeam Research Treating smoking dependence in depressed alcoholics.(Clinical report) - Sep 22, 2006 ...and these effects are blocked by the nicotinic receptor antagonist mecamylamine (for a review, see Larsson and Engel 2004). These results suggest that ... $4.95 - Alcohol Research & Health - ECNext Brand Names/Synonyms: Mecamylamine is also known by the following brand names and/or synonymsVersamine; Inversine; Revertina; Inversine hydrochloride; Mecamilamina; Mecamine; Mecamine hydrochloride; Mecamylamine Hydrochloride; Mekamin hydrochloride; Mekamine; Mevasin hydrochloride; Mevasine; 2-Methylamino-2,3,3-trimethylnorbornane; 2-Methylaminoisocamphane; 2-Norbornanamine, N,2,3,3-tetramethyl-; 2-Norbornanamine, N,2,3,3-tetramethyl-, hydrochloride; 3-Methylaminoisocamphane; 3-Methylaminoisocamphane hydrochloride Drug Category: Mecamylamine is categorized under the following by the FDA: Antihypertensive Agents; Nicotinic Receptor Antagonist ATC:C02BB01 Dosage Forms: Tablets Absorption: Mecamylamine is almost completely absorbed from the gastrointestinal tract Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: N,2,3,3-tetramethylnorbornan-2-amine |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |